These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17462942)
1. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies. Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942 [TBL] [Abstract][Full Text] [Related]
2. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246 [TBL] [Abstract][Full Text] [Related]
10. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878 [TBL] [Abstract][Full Text] [Related]
11. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities. Bottemanne P; Muccioli GG; Alhouayek M Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427 [TBL] [Abstract][Full Text] [Related]
12. Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase. Wang J; Zhao LY; Uyama T; Tsuboi K; Tonai T; Ueda N Biochim Biophys Acta; 2008; 1781(11-12):710-7. PubMed ID: 18793752 [TBL] [Abstract][Full Text] [Related]
13. A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells. Sakura Y; Tsuboi K; Uyama T; Zhang X; Taoka R; Sugimoto M; Kakehi Y; Ueda N Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1951-1958. PubMed ID: 27693242 [TBL] [Abstract][Full Text] [Related]
14. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270 [TBL] [Abstract][Full Text] [Related]
15. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice. Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639 [TBL] [Abstract][Full Text] [Related]
16. Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase. Yamano Y; Tsuboi K; Hozaki Y; Takahashi K; Jin XH; Ueda N; Wada A Bioorg Med Chem; 2012 Jun; 20(11):3658-65. PubMed ID: 22542283 [TBL] [Abstract][Full Text] [Related]
17. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215. Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds. Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199 [TBL] [Abstract][Full Text] [Related]